| First Author | Åbjørsbråten KS | Year | 2022 |
| Journal | Elife | Volume | 11 |
| PubMed ID | 35833623 | Mgi Jnum | J:327137 |
| Mgi Id | MGI:7328225 | Doi | 10.7554/eLife.75055 |
| Citation | Abjorsbraten KS, et al. (2022) Impaired astrocytic Ca(2+) signaling in awake-behaving Alzheimer's disease transgenic mice. Elife 11:e75055 |
| abstractText | Increased astrocytic Ca(2+) signaling has been shown in Alzheimer's disease mouse models, but to date no reports have characterized behaviorally induced astrocytic Ca(2+) signaling in such mice. Here, we employ an event-based algorithm to assess astrocytic Ca(2+) signals in the neocortex of awake-behaving tg-ArcSwe mice and non-transgenic wildtype littermates while monitoring pupil responses and behavior. We demonstrate an attenuated astrocytic Ca(2+) response to locomotion and an uncoupling of pupil responses and astrocytic Ca(2+) signaling in 15-month-old plaque-bearing mice. Using the genetically encoded fluorescent norepinephrine sensor GRABNE, we demonstrate a reduced norepinephrine signaling during spontaneous running and startle responses in the transgenic mice, providing a possible mechanistic underpinning of the observed reduced astrocytic Ca(2+) responses. Our data points to a dysfunction in the norepinephrine-astrocyte Ca(2+) activity axis, which may account for some of the cognitive deficits observed in Alzheimer's disease. |
